North America Electrophysiology Market- Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4387344
  • Report
  • Region: North America, United States
  • 134 pages
  • Mordor Intelligence
1 of 4
The North American electrophysiology (EP) market is set to experience a rapid growth in value over the coming years, climbing from approximately USD 0.72 billion in 2014 to USD 1.6 billion by 2019, at a CAGR of 9.4%.The electrophysiology (EP) market consists of ablation catheters, diagnostic catheters, and lab systems.

North America Electrophysiology Market-Market Dynamics

The report details several driving factors, restraints and opportunities for the market, some of which are listed below.

Drivers

Technological innovations and advancements

Increasing incidence of chronic diseases

Ease of use and interpretation of medical devices

Patient Protection and Affordable Care Act

Increasing healthcare expenditure

Rising adoption of ablation techniques

Restraints

The factors constraining the growth of the market include reimbursement issues and the high cost of the medical devices.

Opportunities

The emerging economies, public awareness for cardiac diseases, and the huge scope for consolidation are the major opportunities in the market.

The report segments the market by types (electrophysiology monitoring devices, treatment devices) and geography (USA, Canada).

The major companies discussed in this report with their profile and relevant information from the market perspective are:

Key Deliverables:

Market analysis for the North American electrophysiology market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the North American electrophysiology market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report description
1.2 Research methodology
2. Executive summary
3. Market overview
3.1 Introduction
3.2 Market size and forecasts
3.3 Market dynamics
3.3.1 Market drivers
3.3.1.1 Rapidly increasing aged population
3.3.1.2 Increasing cases of cardiac diseases
3.3.1.3 Technological advancements
3.3.1.4 Patient Protection and Affordable Care Act
3.3.1.5 Increasing healthcare expenditure
3.3.1.6 Rising adoption of ablation techniques
3.3.2 Market restraints
3.3.2.1 High cost of treatment
3.3.2.2 Regulatory issues
3.3.3 Opportunities
3.3.3.1 Emerging economies
3.3.3.2 Public awareness for cardiac diseases
3.3.3.3 Huge scope for consolidation
3.3.4 Porterfive force analysis
3.3.4.1 Bargaining power of suppliers
3.3.4.2 Bargaining power of buyers
3.3.4.3 Threat of substitutes
3.3.4.4 Threat from new entrants
3.3.4.5 Competitive rivalry
4. Market segmentation
4.1 Market segmentation, by type of products
4.1.1 Electrophysiology monitoring devices
4.1.1.1 Electrocardiograph (ECG)
4.1.1.2 Electroencephalograph (EEG)
4.1.1.3 Electrocorticograph (ECOG)
4.1.1.4 Electromyograph (EMG)
4.1.1.5 Electroretinograph (ERG)
4.1.1.6 Electrooculograph (EOG)
4.1.2 Holter Monitoring Devices
4.1.2.1 X-Ray systems
4.1.2.2 Imaging and 3D mapping systems
4.1.2.3 Diagnostic electrophysiology catheters
4.1.3 Electrophysiology Treatment Devices
4.1.3.1 Implantable cardioverter defibrillators (ICDs)
4.1.3.2 Pacemakers
4.1.3.3 Cardiac resynchronization therapy devices (CRTs)
4.1.3.4 Catheters
4.1.3.4.1 Radiofrequency electrophysiology ablation catheters
4.1.3.4.2 Cryoablation electrophysiology catheters
4.1.3.4.3 Laser ablation catheters
4.1.3.4.4 Microwave ablation catheters
4.2 Market segmentation, by country
4.2.1 US
4.2.2 Canada
5. Competitive landscape
5.1 Mergers/acquisitions
5.2 Collaborations/partnerships
5.3 Product launches/developments
6. Company profiles
6.1 Biosense Webster, Inc.
6.2 St. Jude Medical, Inc.
6.3 Biotronik SE & Co. KG
6.4 Boston Scientific Corporation
6.5 Medtronic, Inc.
7. Appendix
7.1. Abbreviations
7.2. Sources
7.3. Bibliography
7.4. Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll